Skip to content
Recall Observatory FDA recall evidence

Device product

COAPTITE Injectable Implant, injectable, sterile, non-pyrogenic implant composed of spherical particles (75-125 microns in diameter of calcium hydroxylapatite (CaHA), suspended in aqueous based gel carrier. Gel carrier is composed of sodium carboxymethylcellulose, sterile water for injection, and glycerin. Product is packaged in a 1.0cc syringe and packed in a sterile pouch.

Z-0401-2021

September 30, 2020

Class II

Product summary

Firm
Merz North America, Inc.
Event
Event 86572
Status
Ongoing
Classification
Class II
Quantity
2051 units
Official record key
device-enforcement:Z-0401-2021

Official wording

Reason: The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.

Code information: Model M0068903000, Lots: 100127846, 100127847, 100128709, 100128710, 100129357, 100129614, and 100129615

Distribution pattern: US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.